Your commute is pretty easy this morning
At least you may have
had an easier morning
commute. Many banks, businesses and government institutions are closed today for the Memorial Day holiday. The stock markets are also closed.
PLANTING "SEEDS'' FOR A SUSTAINABLE FUTURE, the University of South Florida, the city of St. Petersburg, Progress Energy and the Florida High Tech corridor will unveil a renewable-energy system on Tuesday. The Sustainable Electrical Energy Delivery System "could become the energy storage system of tomorrow's 'Smart Grid' power system." The event begins at 10 a.m. with a panel on "The Future of Power in the State of Florida," at the Nelson Poynter Memorial Library at USF St. Petersburg, 140 7th Ave. S.
COFFEE, TEA OR
PICKETS? Some 13,000 Delta Air Lines flight attendants wrap up voting Wednesday to join the Association of Flight Attendants-CWA. Delta is largely nonunion, and six years ago, only 29 percent of flight attendants voted for AFA representation. But Delta employees have gone through repeated job and salary cuts since then and face a merger with Northwest Airlines. Results of electronic voting that began April 24 should be released by day's end.
ST. PETERSBURG TO VISIT ST. PETERSBURG? Gov. Charlie Crist and an entourage of businesspeople are finalizing plans for a trade mission to Great Britain, France, Spain and Russian from July 12 to 22. The main stop in Russia? Why, St. Petersburg, of course. The trip is scheduled to coincide with the Farnborough International Air Show near London. Business executives looking to sign up this week can call Enterprise Florida at (850) 298-6632.
PROTESTORS: A group protesting the FDA's decision last year to delay approval of a new prostate cancer drug is holding a rally in eight cities, including Tampa, on Friday. The group, CareToLive, will gather at Moffitt Cancer Center from 3 to 5 p.m. The nationwide group of cancer patients and their families has been aggressively fighting the FDA's decision in May 2007 to postpone approval of the experimental drug Provenge made by Dendreon Corp. in Seattle. Moffitt's Dr. James Mule chaired the FDA's Advisory Committee, which advised the FDA to approve the drug; two months later, however, the FDA determined that more data was necessary before it could make a final decision. Approval of Provenge is still pending.